Global Tuberculosis Vaccines market is expected to grow from US$ 78.5 million in 2025 to US$ 93.5 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031.

Global Tuberculosis Vaccines Market Size and Outlook 2025-31

The global Tuberculosis Vaccines market size is predicted to grow from US$ 78.5 million in 2025 to US$ 93.5 million in 2031; it is expected to grow at a CAGR of 2.9% from 2025 to 2031. The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report. Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at an advanced stage the sputum will contain blood and other symptoms include lack of appetite, weight loss, fever, and night sweats. United States market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Tuberculosis Vaccines is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Tuberculosis Vaccines players cover Sanofi, Merck, Serum Institute of India, GlaxoSmithKline, Japan BCG Lab, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Tuberculosis Vaccines Industry Forecast looks at past sales and reviews total world Tuberculosis Vaccines sales in 2024, providing a comprehensive analysis by region and market sector of projected Tuberculosis Vaccines sales for 2025 through 2031. With Tuberculosis Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Vaccines industry. This Insight Report provides a comprehensive analysis of the global Tuberculosis Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Tuberculosis Vaccines market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Vaccines and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Vaccines. This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Vaccines market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Immunotherapeutic Vaccines &nbsp;&nbsp;&nbsp; Booster Vaccines &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospitals &nbsp;&nbsp;&nbsp; Clinics &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; Merck &nbsp;&nbsp;&nbsp; Serum Institute of India &nbsp;&nbsp;&nbsp; GlaxoSmithKline &nbsp;&nbsp;&nbsp; Japan BCG Lab &nbsp;&nbsp;&nbsp; IDT Biologics &nbsp;&nbsp;&nbsp; GreenSignal Bio Pharma &nbsp;&nbsp;&nbsp; Taj Pharmaceuticals &nbsp;&nbsp;&nbsp; Bavarian Nordic &nbsp;&nbsp;&nbsp; China National Biotec Group Key Questions Addressed in this Report What is the 10-year outlook for the global Tuberculosis Vaccines market? What factors are driving Tuberculosis Vaccines market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Tuberculosis Vaccines market opportunities vary by end market size? How does Tuberculosis Vaccines break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Tuberculosis Vaccines Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Tuberculosis Vaccines by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Tuberculosis Vaccines by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Tuberculosis Vaccines Segment by Type &nbsp;2.2.1 Immunotherapeutic Vaccines &nbsp;2.2.2 Booster Vaccines &nbsp;2.2.3 Others &nbsp;2.3 Tuberculosis Vaccines Sales by Type &nbsp;2.3.1 Global Tuberculosis Vaccines Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Tuberculosis Vaccines Sale Price by Type (2020-2025) &nbsp;2.4 Tuberculosis Vaccines Segment by Application &nbsp;2.4.1 Hospitals &nbsp;2.4.2 Clinics &nbsp;2.4.3 Others &nbsp;2.5 Tuberculosis Vaccines Sales by Application &nbsp;2.5.1 Global Tuberculosis Vaccines Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Tuberculosis Vaccines Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Tuberculosis Vaccines Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Tuberculosis Vaccines Breakdown Data by Company &nbsp;3.1.1 Global Tuberculosis Vaccines Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Tuberculosis Vaccines Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Tuberculosis Vaccines Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Tuberculosis Vaccines Revenue by Company (2020-2025) &nbsp;3.2.2 Global Tuberculosis Vaccines Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Tuberculosis Vaccines Sale Price by Company &nbsp;3.4 Key Manufacturers Tuberculosis Vaccines Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Tuberculosis Vaccines Product Location Distribution &nbsp;3.4.2 Players Tuberculosis Vaccines Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Tuberculosis Vaccines by Geographic Region &nbsp;4.1 World Historic Tuberculosis Vaccines Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Tuberculosis Vaccines Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Tuberculosis Vaccines Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Tuberculosis Vaccines Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Tuberculosis Vaccines Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Tuberculosis Vaccines Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Tuberculosis Vaccines Sales Growth &nbsp;4.4 APAC Tuberculosis Vaccines Sales Growth &nbsp;4.5 Europe Tuberculosis Vaccines Sales Growth &nbsp;4.6 Middle East & Africa Tuberculosis Vaccines Sales Growth 5 Americas &nbsp;5.1 Americas Tuberculosis Vaccines Sales by Country &nbsp;5.1.1 Americas Tuberculosis Vaccines Sales by Country (2020-2025) &nbsp;5.1.2 Americas Tuberculosis Vaccines Revenue by Country (2020-2025) &nbsp;5.2 Americas Tuberculosis Vaccines Sales by Type (2020-2025) &nbsp;5.3 Americas Tuberculosis Vaccines Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Tuberculosis Vaccines Sales by Region &nbsp;6.1.1 APAC Tuberculosis Vaccines Sales by Region (2020-2025) &nbsp;6.1.2 APAC Tuberculosis Vaccines Revenue by Region (2020-2025) &nbsp;6.2 APAC Tuberculosis Vaccines Sales by Type (2020-2025) &nbsp;6.3 APAC Tuberculosis Vaccines Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Tuberculosis Vaccines by Country &nbsp;7.1.1 Europe Tuberculosis Vaccines Sales by Country (2020-2025) &nbsp;7.1.2 Europe Tuberculosis Vaccines Revenue by Country (2020-2025) &nbsp;7.2 Europe Tuberculosis Vaccines Sales by Type (2020-2025) &nbsp;7.3 Europe Tuberculosis Vaccines Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Tuberculosis Vaccines by Country &nbsp;8.1.1 Middle East & Africa Tuberculosis Vaccines Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Tuberculosis Vaccines Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Tuberculosis Vaccines Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Tuberculosis Vaccines Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Tuberculosis Vaccines &nbsp;10.3 Manufacturing Process Analysis of Tuberculosis Vaccines &nbsp;10.4 Industry Chain Structure of Tuberculosis Vaccines 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Tuberculosis Vaccines Distributors &nbsp;11.3 Tuberculosis Vaccines Customer 12 World Forecast Review for Tuberculosis Vaccines by Geographic Region &nbsp;12.1 Global Tuberculosis Vaccines Market Size Forecast by Region &nbsp;12.1.1 Global Tuberculosis Vaccines Forecast by Region (2026-2031) &nbsp;12.1.2 Global Tuberculosis Vaccines Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Tuberculosis Vaccines Forecast by Type (2026-2031) &nbsp;12.7 Global Tuberculosis Vaccines Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Sanofi &nbsp;13.1.1 Sanofi Company Information &nbsp;13.1.2 Sanofi Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Sanofi Main Business Overview &nbsp;13.1.5 Sanofi Latest Developments &nbsp;13.2 Merck &nbsp;13.2.1 Merck Company Information &nbsp;13.2.2 Merck Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.2.3 Merck Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Merck Main Business Overview &nbsp;13.2.5 Merck Latest Developments &nbsp;13.3 Serum Institute of India &nbsp;13.3.1 Serum Institute of India Company Information &nbsp;13.3.2 Serum Institute of India Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Serum Institute of India Main Business Overview &nbsp;13.3.5 Serum Institute of India Latest Developments &nbsp;13.4 GlaxoSmithKline &nbsp;13.4.1 GlaxoSmithKline Company Information &nbsp;13.4.2 GlaxoSmithKline Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 GlaxoSmithKline Main Business Overview &nbsp;13.4.5 GlaxoSmithKline Latest Developments &nbsp;13.5 Japan BCG Lab &nbsp;13.5.1 Japan BCG Lab Company Information &nbsp;13.5.2 Japan BCG Lab Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Japan BCG Lab Main Business Overview &nbsp;13.5.5 Japan BCG Lab Latest Developments &nbsp;13.6 IDT Biologics &nbsp;13.6.1 IDT Biologics Company Information &nbsp;13.6.2 IDT Biologics Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 IDT Biologics Main Business Overview &nbsp;13.6.5 IDT Biologics Latest Developments &nbsp;13.7 GreenSignal Bio Pharma &nbsp;13.7.1 GreenSignal Bio Pharma Company Information &nbsp;13.7.2 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.7.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 GreenSignal Bio Pharma Main Business Overview &nbsp;13.7.5 GreenSignal Bio Pharma Latest Developments &nbsp;13.8 Taj Pharmaceuticals &nbsp;13.8.1 Taj Pharmaceuticals Company Information &nbsp;13.8.2 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Taj Pharmaceuticals Main Business Overview &nbsp;13.8.5 Taj Pharmaceuticals Latest Developments &nbsp;13.9 Bavarian Nordic &nbsp;13.9.1 Bavarian Nordic Company Information &nbsp;13.9.2 Bavarian Nordic Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Bavarian Nordic Main Business Overview &nbsp;13.9.5 Bavarian Nordic Latest Developments &nbsp;13.10 China National Biotec Group &nbsp;13.10.1 China National Biotec Group Company Information &nbsp;13.10.2 China National Biotec Group Tuberculosis Vaccines Product Portfolios and Specifications &nbsp;13.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 China National Biotec Group Main Business Overview &nbsp;13.10.5 China National Biotec Group Latest Developments 14 Research Findings and Conclusion

Report	Global Tuberculosis Vaccines Market Growth 2025-2031
Selected License	Multi ID: LPI24070

Buyer Information

Order Summary